BioSurface Technologies
Private Company
Total funding raised: $22.2M
Overview
BioSurface Technologies is a long-established, niche player in the research tools sector, providing essential laboratory equipment for biofilm investigation. The company's core business is the design and sale of physical reactor systems and flow cells that enable standardized, reproducible biofilm growth and analysis for academic, industrial, and public health laboratories. Its products are often developed in partnership with authoritative entities like the CDC and the Center for Biofilm Engineering, lending them credibility and establishing them as ASTM-approved methods. BST operates as a private, revenue-generating business model focused on serving the global research community with specialized hardware.
Technology Platform
Hardware platform for reproducible biofilm cultivation and analysis, including licensed reactor designs (CDC, Annular, Drip Flow) and microscopy flow cells.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
BST occupies a unique position as the sole licensed manufacturer of several industry-standard biofilm reactors, giving it a significant competitive moat. Competition likely comes from academic labs building custom reactors, generic lab equipment suppliers, and specialized startups focusing on subsets of the market (e.g., microfluidic biofilm chips).